Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey

Table 4 Number of hospitalisations due to schizophrenia relapse and number of suicide attempts

	Overall		US		France		Spain		Japan		China
	LAI	Non-LAI	LAI	Non-LAI	LAI	Non-LAI	LAI	Non-LAI	LAI	Non-LAI	LAI	Non-LAI
Number of patients	467	1496	66	211	123	172	216	209	18	162	44	742
Number of hospitalisations prior to first LAI, mean (SD)	2.2 (2.9)***	1.6 (2.9)	1.7 2.9)	1.5 (3.3)	2.6 (3.2)*	3.8 (5.4)	2.3 (2.8)	2.6 (3.1)	1.4 (2.4)	1.2 (1.8)	1.1 (1.5)	0.9 (1.2)
Number of patients	996	2783	205	723	296	401	390	375	84	434	52	922
Number of suicide attempts, mean (SD)	0.4 (1.0)**	0.3 (1.3)	0.5 (1.0)	0.4 (2.0)	0.6 (1.1)	0.5 (1.3)	0.4 (0.9)	0.3 (0.7)	0.4 (0.9)*	0.2 (0.6)	0.1 (0.4)	0.2 (0.6)

*p≤0.05; **p≤0.01; ***p≤0.0001
Blank cells indicate no change in sample size from the overall number of patients presented at the outset of the table. Where sample size varies, ‘n’ number is stated
LAI long-acting injectable, SD standard deviation, US United States

ISSN: 1471-244X